Intrust Bank’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $237K | Buy |
+4,947
| New | +$213K | 0.02% | 385 |
|
|
2026
Q1 | – | Sell |
-5,215
| Closed | -$265K | – | 419 |
|
|
2025
Q4 | $265K | Sell |
5,215
-119
| -2% | -$6.08K | 0.02% | 355 |
|
|
2025
Q3 | $296K | Sell |
5,334
-1,131
| -17% | -$66.2K | 0.02% | 340 |
|
|
2025
Q2 | $446K | Sell |
6,465
-895
| -12% | -$60.9K | 0.04% | 269 |
|
|
2025
Q1 | $511K | Sell |
7,360
-1,357
| -16% | -$112K | 0.05% | 234 |
|
|
2024
Q4 | $750K | Buy |
8,717
+281
| +3% | +$30.4K | 0.08% | 188 |
|
|
2024
Q3 | $1M | Buy |
8,436
+528
| +7% | +$70.4K | 0.1% | 154 |
|
|
2024
Q2 | $1.13M | Buy |
7,908
+112
| +1% | +$14.8K | 0.12% | 131 |
|
|
2024
Q1 | $1M | Buy |
7,796
+402
| +5% | +$47.9K | 0.11% | 151 |
|
|
2023
Q4 | $765K | Buy |
7,394
+2,685
| +57% | +$266K | 0.09% | 188 |
|
|
2023
Q3 | $428K | Sell |
4,709
-9
| -0.2% | -$793 | 0.05% | 256 |
|
|
2023
Q2 | $382K | Buy |
4,718
+388
| +9% | +$31.7K | 0.05% | 279 |
|
|
2023
Q1 | $345K | Sell |
4,330
-80
| -2% | -$5.67K | 0.04% | 287 |
|
|
2022
Q4 | $298K | Hold |
4,410
| – | – | 0.04% | 310 |
|
|
2022
Q3 | $219K | Sell |
4,410
-74
| -2% | -$3.96K | 0.03% | 342 |
|
|
2022
Q2 | $250K | Hold |
4,484
| – | – | 0.04% | 327 |
|
|
2022
Q1 | $249K | Sell |
4,484
-892
| -17% | -$45.8K | 0.03% | 347 |
|
|
2021
Q4 | $301K | Hold |
5,376
| – | – | 0.04% | 324 |
|
|
2021
Q3 | $258K | Buy |
+5,376
| New | +$260K | 0.03% | 331 |
|
|
2016
Q4 | – | Sell |
-10,558
| Closed | -$219K | – | 357 |
|
|
2016
Q3 | $219K | Hold |
10,558
| – | – | 0.09% | 320 |
|
|
2016
Q2 | $284K | Sell |
10,558
-2,166
| -17% | -$59.4K | 0.11% | 261 |
|
|
2016
Q1 | $345K | Sell |
12,724
-776
| -6% | -$20.8K | 0.12% | 203 |
|
|
2015
Q4 | $392K | Buy |
13,500
+58
| +0.4% | +$1.6K | 0.15% | 180 |
|
|
2015
Q3 | $365K | Sell |
13,442
-2,704
| -17% | -$76.6K | 0.14% | 183 |
|
|
2015
Q2 | $442K | Sell |
16,146
-376
| -2% | -$10.6K | 0.15% | 173 |
|
|
2015
Q1 | $441K | Sell |
16,522
-274
| -2% | -$6.31K | 0.16% | 171 |
|
|
2014
Q4 | $355K | Sell |
16,796
-6,230
| -27% | -$139K | 0.13% | 189 |
|
|
2014
Q3 | $548K | Sell |
23,026
-408
| -2% | -$9.39K | 0.21% | 140 |
|
|
2014
Q2 | $541K | Buy |
23,434
+1,872
| +9% | +$41.3K | 0.2% | 150 |
|
|
2014
Q1 | $492K | Sell |
21,562
-4,158
| -16% | -$88.6K | 0.2% | 151 |
|
|
2013
Q4 | $475K | Sell |
25,720
-1,460
| -5% | -$25.4K | 0.21% | 151 |
|
|
2013
Q3 | $459K | Sell |
27,180
-12,790
| -32% | -$215K | 0.22% | 150 |
|
|
2013
Q2 | $620K | Buy |
+39,970
| New | +$665K | 0.28% | 131 |
|
Other funds holding NVO
F
Intrust Bank's NVO Position: Q2 2026 in Review
Intrust Bank opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,947 shares worth $237K. The stake represents 0.02% of the portfolio and ranks #385 among its holdings. This is a return to the name: Intrust Bank previously reported a position in NVO as recently as Q4 2025.
Intrust Bank first reported a position in NVO in Q2 2013 and has held it in 33 quarters since. The position peaked at $1.13M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Intrust Bank held 4,947 shares of Novo Nordisk worth $237K as of Q2 2026.
- Novo Nordisk was a new Intrust Bank position in Q2 2026.
- Novo Nordisk made up 0.02% of Intrust Bank's portfolio in Q2 2026, its #385 holding.
- Intrust Bank first reported a position in Novo Nordisk in Q2 2013 and has held it in 33 quarters since.
- Intrust Bank's Novo Nordisk position peaked at $1.13M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Intrust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.